N
NKTX icon

Nuveen’s Nkarta NKTX Stock Holding History

Nuveen’s Portfolio NKTX Stock Details NKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$941K Buy
445,798
+255,115
+134% +$571K ﹤0.01% 2608
2025
Q4 		$353K Buy
190,683
+95,120
+100% +$190K ﹤0.01% 2999
2025
Q3 		$198K Sell
95,563
-35,176
-27% -$72.2K ﹤0.01% 3152
2025
Q2 		$217K Sell
130,739
-9,374
-7% -$17.2K ﹤0.01% 3137
2025
Q1 		$258K Hold
140,113
– – ﹤0.01% 3065
2024
Q4 		$349K Buy
140,113
+21,627
+18% +$66.8K ﹤0.01% 3092
2024
Q3 		$536K Sell
118,486
-153,910
-57% -$875K ﹤0.01% 2993
2024
Q2 		$1.61M Buy
272,396
+39,306
+17% +$278K ﹤0.01% 2489
2024
Q1 		$2.52M Buy
233,090
+141,162
+154% +$1.47M ﹤0.01% 2291
2023
Q4 		$607K Buy
91,928
+10,535
+13% +$27.3K ﹤0.01% 2940
2023
Q3 		$113K Sell
81,393
-404,500
-83% -$767K ﹤0.01% 3114
2023
Q2 		$1.06M Sell
485,893
-2,430
-0.5% -$10.7K ﹤0.01% 2632
2023
Q1 		$1.73M Sell
488,323
-273,692
-36% -$1.3M ﹤0.01% 2389
2022
Q4 		$4.56M Buy
762,015
+71,595
+10% +$723K ﹤0.01% 1963
2022
Q3 		$9.09M Buy
690,420
+339,858
+97% +$4.86M ﹤0.01% 1534
2022
Q2 		$4.32M Buy
350,562
+291,734
+496% +$3.83M ﹤0.01% 2042
2022
Q1 		$679K Buy
58,828
+560
+1% +$5.99K ﹤0.01% 2926
2021
Q4 		$772K Sell
58,268
-4,197
-7% -$72K ﹤0.01% 2942
2021
Q3 		$1.96M Sell
62,465
-19,940
-24% -$632K ﹤0.01% 2678
2021
Q2 		$2.61M Sell
82,405
-10,246
-11% -$295K ﹤0.01% 2578
2021
Q1 		$3.05M Buy
92,651
+23,567
+34% +$1.13M ﹤0.01% 2412
2020
Q4 		$4.25M Buy
69,084
+5,613
+9% +$233K ﹤0.01% 2158
2020
Q3 		$1.91M Buy
+63,471
New +$1.87M ﹤0.01% 2405

Other funds holding NKTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
GP
GSK plc London $599M AUM
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nuveen's NKTX Position: Q1 2026 in Review

Nuveen increased its Nkarta (NKTX) stake by 134% in Q1 2026, buying an estimated $571K and bringing the position to 445,798 shares worth $941K. The position accounts for ﹤0.01% of the portfolio, ranked #2608.

Nuveen first reported a position in NKTX in Q3 2020 and has held it in 23 quarters since. The position peaked at $9.09M in Q3 2022. 126 funds tracked by Wall St. Rank hold NKTX as of Q1 2026.

  • Nuveen held 445,798 shares of Nkarta worth $941K as of Q1 2026.
  • Nuveen bought 255,115 Nkarta shares in Q1 2026, an estimated $571K.
  • Nkarta made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2608 holding.
  • Nuveen first reported a position in Nkarta in Q3 2020 and has held it in 23 quarters since.
  • Nuveen's Nkarta position peaked at $9.09M in Q3 2022.
  • 126 funds tracked by Wall St. Rank held Nkarta as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.